Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
obesity drugs
Pharma
Lilly cuts revenue guidance as momentum stalls for tirzepatide
Sales of Eli Lilly’s tirzepatide products fell far short of expectations in Q3, leading the juggernaut company to reduce its annual revenue guidance.
Kevin Dunleavy
Oct 30, 2024 9:47am
UK warns GLP-1s not for 'body beautiful picture for Instagram'
Oct 25, 2024 8:20am
Weight loss drug maker Currax runs campaign against food noise
Sep 24, 2024 12:36pm
Lilly markets single-dose Zepbound vials at a major price cut
Aug 27, 2024 11:14am
Novo re-ups supplies on most doses of obesity med Wegovy
Aug 7, 2024 12:49pm
Novo's Wegovy scores key cardiovascular label expansion
Mar 8, 2024 3:51pm
